Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ryaltris in pediatric seasonal allergic rhinitis
NCT03463031Phase 3Completed
- Sponsor
- Glenmark Specialty
- Start
- Mar 2018
- Primary completion
- Nov 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of mometasone in seasonal allergic rhinitis (SAR), sponsored by Glenmark Specialty. Started Mar 2018; status: completed.
02
Drugs
mometasone
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT03463031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03463031.